 
                                  Time and Severe Hypoperfusion: 2 Threats for Hemorrhagic Transformation in Stroke
International Journal of Stroke (IJS) recently shared a post on X:
”Just Accepted!
Study finds hemorrhagic transformation was associated with onset-to-imaging time and presence of severe hypoperfusion. No interaction found between time and severe hypoperfusion.”
Read the full article here.
A new study is reinforcing the importance of timely management of stroke in an article ‘Association between Time and Severe Hypoperfusion with Risk of Hemorrhagic Transformation in Stroke Patients’ by Umberto Pensato et al., published in International Journal of Stroke (IJS).
Emerging evidence highlights that both severe hypoperfusion and time spent in a hypoperfused state contribute to the risk of parenchymal hematoma (PH) in ischemic stroke.
A recent analysis confirms that while each factor independently increases the likelihood of hemorrhagic transformation (HT), their interaction was not statistically significant.
These findings suggest that the risk of HT is influenced by distinct pathways related to hypoperfusion severity and duration.
Identifying patients with a “leaky core”—those with severely compromised blood-brain barriers—could enhance patient selection for targeted interventions!

Hemostasis Today, your daily update on scientific advancements in the World of Stroke.
- 
                    Oct 30, 2025, 12:12Laura Ceci Galanos Reflects on WSC 2025
- 
                    Oct 30, 2025, 03:53Michael Makris on Biomarin's Decision to Divest Roctavian
- 
                    Oct 29, 2025, 10:39UMR1011 Researchers at ECTH 2025
- 
                    Oct 29, 2025, 07:09Hritvik Jain and Andrew Goldsweig Sharedrisk About the Risk of MACCE, AMI, and readmission in IBD patients undergoing PCI
- 
                    Oct 29, 2025, 07:07Flora Peyvandi Shared an Article About Menstrual Bleeding and Bleeding Tendency in Dutch Adolescents
- 
                    Oct 30, 2025, 05:14Umberto Pensato on Reperfusion Outcomes in Stroke
- 
                    Oct 29, 2025, 07:18Osimertinib Has Transformed Lung Cancer Care — But at What Cost to the Heart?
- 
                    Oct 29, 2025, 07:15From the Lab to Prague․ Our ECTH 2025 Experience
- 
                    Oct 29, 2025, 07:13Amol Akhade: Happy To Share Our Paper Published In Lancet Oncology
- 
                    Oct 29, 2025, 07:09Davide Capodanno: This Time It’s About the Timing of Complete Revascularization in ACS
- 
                    Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
- 
                    Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
- 
                    Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
- 
                    Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
- 
                    Oct 27, 2025, 09:19Mitra Najafi: Digital Storage Device - Specifically Designed and Developed to Store and Preserve PRP
- 
                    Oct 30, 2025, 11:56Lucas de Vries Defends His PHD Combining Physics, Deep Learning and Medical Imaging
- 
                    Oct 30, 2025, 03:50Laura Bouvet Receives the Young Investigator Award at ECTH 2025
- 
                    Oct 29, 2025, 08:30ECTH 2025․ Advancing the Science of Thrombosis and Haemostasis Together
- 
                    Oct 28, 2025, 06:59Wim van den Broek Attended ECTH in Prague
- 
                    Oct 28, 2025, 06:46Alexandre Kauskot Attended ECTH in Prague
